Patent delisted for Astrazeneca Ab drug BYDUREON PEN
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one […]
Patent delisted for Astrazeneca Ab drug BYDUREON PEN Read Post »
Patent Expiration
Patent delisted for Teva Pharms drug COPAXONE
Annual Drug Patent Expirations for COPAXONE Copaxone is a drug marketed by Teva Pharms Usa and is included in one
Patent delisted for IMPAX drug ADRENACLICK
Annual Drug Patent Expirations for ADRENACLICK Adrenaclick is a drug marketed by Impax and is included in one NDA. It
Patent delisted for IMPAX drug TWINJECT 0.15
Annual Drug Patent Expirations for TWINJECT+0.15 Twinject 0.15 is a drug marketed by Impax and is included in one NDA.
Patent delisted for IMPAX drug TWINJECT 0.3
Annual Drug Patent Expirations for TWINJECT+0.3 Twinject 0.3 is a drug marketed by Impax and is included in one NDA.
Patent delisted for Abbvie drug NORVIR
Annual Drug Patent Expirations for NORVIR Norvir is a drug marketed by Abbott, Abbvie, and Abbvie Inc and, and is
Patent delisted for Veloxis Pharms drug ENVARSUS XR
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in
Patent delisted for Veloxis Pharms drug ENVARSUS XR Read Post »
Patent delisted for Otsuka drug ABILIFY MYCITE KIT
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one
Patent delisted for Otsuka drug ABILIFY MYCITE KIT Read Post »
Patent delisted for Taiho Oncology drug LONSURF
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA.
